Four years ago, Bill Gates led an effort in which he and a few other billionaires, including Jeff Bezos and MacKenzie Scott, pledged $30 million to create a new engine inside an Alzheimer’s foundation to speed up development of tests that could diagnose the disease. That funding later grew to $50 million.
A company called RetiSpec, backed in part by the foundation, is developing a retinal test that detects neurodegenerative changes. “The eye is the window to the brain,” explains Fillit, who envisions a scenario where you may go for your eye checkup once a year and have extra imaging performed that could detect Alzheimer’s disease less invasively than current tests do.
Read the full article on Forbes